Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Opening up the Window into “Chemobrain”: A Neuroimaging Review
Carole Scherling, Andra Smith
Sensors (2013) Vol. 13, Iss. 3, pp. 3169-3203
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
Theoharis C. Theoharides, Christos Cholevas, Konstantinos S. Polyzoidis, et al.
BioFactors (2021) Vol. 47, Iss. 2, pp. 232-241
Open Access | Times Cited: 187
Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis
Alexandra L. Whittaker, Rebecca P. George, Lucy O’Malley
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 105
Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: A systematic review
Mingmei Li, Karen Caeyenberghs
Neuroscience & Biobehavioral Reviews (2018) Vol. 92, pp. 304-317
Closed Access | Times Cited: 107
The Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-“Chemobrain”
Amelia Maria Găman, Adriana Uzoni, Aurel Popa‐Wagner, et al.
Aging and Disease (2016) Vol. 7, Iss. 3, pp. 307-307
Open Access | Times Cited: 99
Default mode network as a potential biomarker of chemotherapy-related brain injury
Shelli R. Kesler
Neurobiology of Aging (2014) Vol. 35, pp. S11-S19
Open Access | Times Cited: 94
A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients
Christian Lepage, Andra Smith, Jeremy T. Moreau, et al.
SpringerPlus (2014) Vol. 3, Iss. 1
Open Access | Times Cited: 94
Brain network alterations and vulnerability to simulated neurodegeneration in breast cancer
Shelli R. Kesler, Christa Watson, Douglas W. Blayney
Neurobiology of Aging (2015) Vol. 36, Iss. 8, pp. 2429-2442
Open Access | Times Cited: 82
Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment
Charlene Treanor, Úna C. McMenamin, Roisin F O'Neill, et al.
Cochrane library (2016) Vol. 2022, Iss. 1
Open Access | Times Cited: 80
Hippocampal functional connectivity is related to self-reported cognitive concerns in breast cancer patients undergoing adjuvant therapy
Alexandra C. Apple, M. Schroeder, Anthony J. Ryals, et al.
NeuroImage Clinical (2018) Vol. 20, pp. 110-118
Open Access | Times Cited: 77
Baseline cognitive functions among elderly patients with localised breast cancer
Marie Lange, Bénédicte Giffard, Sabine Noal, et al.
European Journal of Cancer (2014) Vol. 50, Iss. 13, pp. 2181-2189
Open Access | Times Cited: 76
Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine
Philipp Zimmer, Andreas Mierau, Wilhelm Bloch, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2014) Vol. 56, Iss. 2, pp. 347-352
Closed Access | Times Cited: 71
A novel preventive therapy for paclitaxel-induced cognitive deficits: preclinical evidence from C57BL/6 mice
Petra Huehnchen, Wolfgang Boehmerle, Andreas Springer, et al.
Translational Psychiatry (2017) Vol. 7, Iss. 8, pp. e1185-e1185
Open Access | Times Cited: 62
Brain fog in central disorders of hypersomnolence: a review
Russell Rosenberg, Michael J. Thorpy, Karl Doghramji, et al.
Journal of Clinical Sleep Medicine (2024) Vol. 20, Iss. 4, pp. 643-651
Closed Access | Times Cited: 6
Reduced prefrontal activation during working and long‐term memory tasks and impaired patient‐reported cognition among cancer survivors postchemotherapy compared with healthy controls
Lei Wang, Alexandra C. Apple, M. Schroeder, et al.
Cancer (2015) Vol. 122, Iss. 2, pp. 258-268
Open Access | Times Cited: 44
Objective–subjective disparity in cancer‐related cognitive impairment: does the use of change measures help reconcile the difference?
Erin O’Farrell, Andra Smith, Barbara Collins
Psycho-Oncology (2016) Vol. 26, Iss. 10, pp. 1667-1674
Closed Access | Times Cited: 43
Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer
Bihong T. Chen, Taihao Jin, Sunita K. Patel, et al.
Breast Cancer Research and Treatment (2018) Vol. 172, Iss. 2, pp. 363-370
Open Access | Times Cited: 38
Frontal hypometabolism in elderly breast cancer survivors determined by [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET): a pilot study
Laura L. Boles Ponto, Yusuf Menda, Vincent A. Magnotta, et al.
International Journal of Geriatric Psychiatry (2014) Vol. 30, Iss. 6, pp. 587-594
Open Access | Times Cited: 36
A systemic literature review of neuroimaging studies in women with breast cancer treated with adjuvant chemotherapy
Paulina Andryszak, Monika Wiłkość-Dębczyńska, Paweł Izdebski, et al.
Współczesna Onkologia (2017) Vol. 1, pp. 6-15
Open Access | Times Cited: 34
Chemo-brain: An activation likelihood estimation meta-analysis of functional magnetic resonance imaging studies
Lori J. Bernstein, Kim Edelstein, Alisha Sharma, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 130, pp. 314-325
Closed Access | Times Cited: 24
Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events
Ana Dias-Carvalho, Mariana Ferreira, Rita Ferreira, et al.
Archives of Toxicology (2021) Vol. 96, Iss. 1, pp. 11-78
Closed Access | Times Cited: 21
Baseline Cognition Assessment Among Patients With Oropharyngeal Cancer Using PROMIS and NIH Toolbox
Parul Sinha, Alex Wong, Dorina Kallogjeri, et al.
JAMA Otolaryngology–Head & Neck Surgery (2018) Vol. 144, Iss. 11, pp. 978-978
Open Access | Times Cited: 26
Early manifestation of mild cognitive impairment in B-cell non-Hodgkin’s lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy
Mohd Ashif Khan, Kamlesh Garg, Dinesh Bhurani, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2016) Vol. 389, Iss. 12, pp. 1253-1265
Closed Access | Times Cited: 24
Inhibition of dual leucine zipper kinase prevents chemotherapy-induced peripheral neuropathy and cognitive impairments
Jiacheng Ma, Sunil Goodwani, Paul Acton, et al.
Pain (2021) Vol. 162, Iss. 10, pp. 2599-2612
Open Access | Times Cited: 20
Melatonin mitigates cisplatin-induced cognitive impairment in rats and improves hippocampal dendritic spine density
Shahd Qutifan, Tareq Saleh, Nisreen Abu Shahin, et al.
Neuroreport (2024) Vol. 35, Iss. 10, pp. 657-663
Closed Access | Times Cited: 2
Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis
Hyunwoo Lee, Kunio Nakamura, Sridar Narayanan, et al.
Multiple Sclerosis Journal (2017) Vol. 24, Iss. 8, pp. 1055-1066
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top